Clopidogrel loading in acute Ischemic stroke

Abstract

While current therapies such as tissue plasminogen activator (rTPA) and revascularization are effective in the acute management of ischemic stroke and transient ischemic attack (TIA), the majority of patients are ineligible to receive them. As it must be administered within 4.5 hours of symptom onset. This small treatment window effectively eliminates the majority of patients, such as those who do not know that they are having a stroke, those who cannot articulate because they are having a stroke, those who live in remote areas, and those who live alone or if patient can’t afford or it is not available.